Literature DB >> 23222385

Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT).

J A Steuter1, M L H Villanueva, F R Loberiza, J O Armitage, R G Bociek, A K Ganti, S R Tarantolo, J M Vose, A Easley, P J Bierman.   

Abstract

The use of autologous hematopoietic SCT (auto-HSCT) has expanded to include older patients. Increasing age is a well-appreciated risk factor for the development of atrial fibrillation and/or atrial flutter (AF/AFL) in the general population. As more elderly patients undergo auto-HSCT, the risk of developing AF/AFL post transplant may also increase. However, few data evaluating other risk factors for the development of AF/AFL following auto-HSCT exist. Therefore, we performed a retrospective study to determine the incidence of AF/AFL following auto-HSCT and to determine the risk factors associated with the development of AF/AFL. Patients who developed AF/AFL were compared with a group of patients who received auto-HSCT within the same time period (April 1999 to May 2005) and were within 5 years of age. Of the 516 patients who underwent auto-HSCT at the University of Nebraska Medical Center 44 (8.5%) developed AF/AFL at a median time of 4 days (range, days 1-9) following auto-HSCT. In multivariate analysis, risk factors for developing AF/AFL were older age, odds ratio and 95% CI of 1.14 (1.07-1.21), elevated serum creatinine level, 2.69 (1.00-7.22), history of previous arrhythmia, 9.33 (3.01-28.99), and history of previous mediastinal irradiation, 11.12 (1.33-92.96).

Entities:  

Mesh:

Year:  2012        PMID: 23222385     DOI: 10.1038/bmt.2012.253

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

Review 1.  Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation.

Authors:  Seth J Rotz; Thomas D Ryan; Salim S Hayek
Journal:  J Thromb Thrombolysis       Date:  2020-11-24       Impact factor: 2.300

2.  Arrhythmias in the setting of hematopoietic cell transplants.

Authors:  E S Tonorezos; E E Stillwell; J J Calloway; T Glew; J D Wessler; B J Rebolledo; A Pham; R M Steingart; H Lazarus; R P Gale; A A Jakubowski; W L Schaffer
Journal:  Bone Marrow Transplant       Date:  2015-06-01       Impact factor: 5.483

3.  Left Atrial Mechanics Associates With Paroxysmal Atrial Fibrillation in Light-Chain Amyloidosis Following Stem Cell Transplantation.

Authors:  Graham Lohrmann; Monica Arun Patel; Dina Brauneis; Vaishali Sanchorawala; Shayna Sarosiek; Nirupama Vellanki; Omar K Siddiqi; Frederick L Ruberg; Deepa M Gopal
Journal:  JACC CardioOncol       Date:  2020-12-15

4.  Atrial Fibrillation in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

Authors:  Ellen K Chang; Dayana Chanson; Jennifer Berano Teh; Aleksi Iukuridze; Kelly Peng; Stephen J Forman; Ryotaro Nakamura; F Lennie Wong; LiYing Cai; Saro H Armenian
Journal:  J Clin Oncol       Date:  2021-01-08       Impact factor: 44.544

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.